Contact
Spanish

Midatech is a nanomedicine company focused on the development and commercialisation of multiple, high-value, targeted therapies for major diseases with unmet medical need.

Midatech is advancing a pipeline of novel clinical and pre-clinical product candidates based on its proprietary drug conjugate and sustained release delivery platforms with a clear focus on the key therapeutic areas of diabetes, cancer and neuroscience/ophthalmology. Midatech’s strategy is to develop its products in-house in rare cancers and with partners in other indications, and to accelerate growth of its business through strategic acquisition of complementary products and technologies.

Latest News...
Feb 18, 2015
Midatech Pharma (AIM: MTPH) , a nanomedicine company developing and commercialising multiple therapeutic... Read More
Feb 9, 2015
Midatech Pharma (AIM: MTPH) , a nanomedicine company developing and commercialising multiple therapeutic... Read More
Jan 20, 2015
This month Midatech Biogune S.L., part of the Midatech Pharma group, has completed the refit of its plant... Read More
Home

Careers

T&Cs

Privacy and cookie policy

Sitemap

  © Copyright 2014 Midatech